MVZ Lumedico offers eye treatments and surgeries including LASIK, cataract operations, and aesthetic medicine services. The organization operates in multiple locations in Düsseldorf and surrounding areas, focusing on eye care.

MVZ Lumedico

Augenarzt Dr. med. Claus Thimm provides services related to eye health, including treatment for cataracts and laser eye procedures. The practice focuses on improving patients' vision and overall eye care.

Augenarzt Dr. med. Claus Thimm

Augenklinik Sulzbach is engaged in providing a full spectrum of operative and conservative ophthalmology services at a high scientific level with modern technical equipment. It attends to over 200 patients daily with eye ailments, employing a team of 37 specialized doctors and over 100 non-medical staff.

Augenklinik Sulzbach

A leading international hospital providing top-level care, research, and teaching in various medical fields.

University Hospital of Düsseldorf (UKD)

MVZ Lumedico is an eye center in Düsseldorf specializing in ophthalmology, including services for laser eye surgery, cataract operations, and aesthetic medicine. The facility offers multiple locations and performs outpatient surgeries.

Metric
Company Name	MVZ Lumedico	Augenarzt Dr. med. Claus Thimm	Augenklinik Sulzbach	University Hospital of Düsseldorf (UKD)
Symbol
MSH ID	COM:LUMEDICO	DE:AUGENARZT-THIMM	DE:AUGENKLINIK-SULZBACH	DE:UNIKLINIK-DUESSELDORF
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Ophthalmology	Medical Services	Healthcare	Healthcare
Country	DE	DE	DE
Stage
Employee Count				1.05K
Website	lumedico.com	augenarzt-thimm.de	augenklinik-sulzbach.de	uniklinik-duesseldorf.de
LinkedIn	lumedico		augenklinik-sulzbach	universit%C3%A4tsklinikum-d%C3%BCsseldorf
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic				286.71K
Web Traffic Growth				0.50
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

LUME

COM:LUMEDICO

MVZ Lumedico

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue